Status:
COMPLETED
Journey for Control of Diabetes Study (0431-111)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Behavior change and self-efficacy are key for patients with diabetes to sustain blood sugar goals, but most care systems do not provide effective support to assist patients in successful ongoing self-...
Eligibility Criteria
Inclusion
- Type 2 Diabetes Mellitus
Exclusion
- Gestational diabetes
- Type 1 Diabetes Mellitus
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
621 Patients enrolled
Trial Details
Trial ID
NCT00652509
Start Date
May 1 2008
End Date
July 1 2011
Last Update
April 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.